
    
      Subjects 4-6 years of age will be randomized into two groups to receive either Kinrix,
      Varivax and M-M-RII on day 0 (Group 1) or Kinrix and M-M-RII on day 0 and Varivax at month
      1(Group 2).

      All subjects in both groups to provide blood samples prior to vaccination on day 0 and at
      month 1 (for Group 2, blood sampling is prior to vaccination with Varivax).

      Duration of the study will be approximately 6 months for each subject with a safety telephone
      contact 6 months after vaccinations.
    
  